Adverse Events in Acute Limb Ischemic Patient Undergoing Revascularization

Incidence and Risk Factors of in Hospital Adverse Events in Acute Limb Ischemic Patient Undergoing Revascularization Treatment: a Retrospective Cohort Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05362266

Enrollment

240

Registered

2022-05-05

Start date

2022-04-10

Completion date

2023-04-01

Last updated

2022-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Effect of Unspecified General Anesthetic, Major Adverse Cardiac Events

Brief summary

Acute limb ischemia is one of the devastating vascular emergencies that lead to life and limb loss if the appropriate treatment is not reached.The revascularization is a cornerstone in treating acute limb ischemia. The conventional surgical approach includes surgical embolectomy and surgical bypass.From the anesthetic aspect, this emergency condition limits the lengthening cardiovascular assessment of this high-risk patient group which might lead to the uncertainty outcome.With the variety of patients and procedures, we sought to find out the perioperative adverse events, especially major adverse cardiac events, in acute ischemic limb patients undergoing revascularization, in order to increase awareness of the team and properly admit to ICU in a retrospective manner.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* age more than 18 years * undergoing revascularization surgery or procedure (surgical revascularization, endovascular revascularization, hybrid revascularization, catheter directed thrombolysis)

Exclusion criteria

* incomplete data during perioperative period

Design outcomes

Primary

Measure	Time frame	Description
Incidence of major adverse cardiac events	during hospital stay, up to 4 weeks	Incidence of major adverse cardiac events, which are cardiovascular death, myocardial infarction, stroke

Secondary

Measure	Time frame	Description
Incidence of the perioperative complication	during hospital stay, up to 4 weeks	Incidence of the perioperative other complication, which are major bleeding, repercussion syndrome, compartment syndrome, rhabdomyolysis and unplanned ICU admission from any causes.
Factors contribute to the adverse outcome	during hospital stay, up to 4 weeks	Factors contribute to the adverse outcome, which are the patients' condition and the underlying diseases, the surgical intervention and the anesthetic technique.

Countries

Thailand

Contacts

Primary ContactTachawan Jirativanont, MD

tachawan.jir@mahidol.acth+66816422817

Outcome results